Why the study?
Does heparan sulfate induce apoptosis or necroptosis in murine cardiomyocytes?
Does heparan sulfate induce apoptosis or necroptosis in murine cardiomyocytes?
Heparan sulfate induces necroptosis and apoptosis in murine cardiomyocytes, suggesting it may be a therapeutic target in trauma- or sepsis-associated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support HS as target in sepsis-associated cardiomyopathy; hypothesis-generating from murine cardiomyocytes.
Life-threatening cardiomyopathy is a severe, but common, complication associated with severe trauma or sepsis. Several signaling pathways involved in apoptosis and necroptosis are linked to trauma- or sepsis-associated cardiomyopathy. However, the underling causative factors are still debatable. Heparan sulfate (HS) fragments belong to the class of danger/damage-associated molecular patterns liberated from endothelial-bound proteoglycans by heparanase during tissue injury associated with trauma or sepsis. We hypothesized that HS induces apoptosis or necroptosis in murine cardiomyocytes. By using a novel Medical- In silico approach that combines conventional cell culture experiments with machine learning algorithms, we aimed to reduce a significant part of the expensive and time-consuming cell culture experiments and data generation by using computational intelligence (refinement and replacement). Cardiomyocytes exposed to HS showed an activation of the intrinsic apoptosis signal pathway via cytochrome C and the activation of caspase 3 (both p < 0.001). Notably, the exposure of HS resulted in the induction of necroptosis by tumor necrosis factor α and receptor interaction protein 3 ( p < 0.05; p < 0.01) and, hence, an increased level of necrotic cardiomyocytes. In conclusion, using this novel Medical- In silico approach, our data suggest (i) that HS induces necroptosis in cardiomyocytes by phosphorylation (activation) of receptor-interacting protein 3, (ii) that HS is a therapeutic target in trauma- or sepsis-associated cardiomyopathy, and (iii) indicate that this proof-of-concept is a first step toward simulating the extent of activated components in the pro-apoptotic pathway induced by HS with only a small data set gained from the in vitro experiments by using machine learning algorithms.
No takes yet. Share an insight, caveat, or question.
Zechendorf et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: